BioCentury | Apr 9, 2015
Translation in Brief

German translation

...include GenGraf cyclosporine from AbbVie Inc. and Neoral cyclosporine modified from Novartis AG . GenGraf and Neoral...
BioCentury | Jun 23, 2014
Company News

Novartis A pharmaceuticals news

...everolimus; hematology drug Exjade deferasirox; acromegaly and neuroendocrine tumor drug Sandostatin octreotide acetate; autoimmune drug Neoral...
BioCentury | Jul 20, 2009
Clinical News

Rapamune sirolimus regulatory update

...Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Wyeth (NYSE:WYE), Madison, N.J. Product: Rapamune sirolimus; Sandimmune cyclosporine; Neoral cyclosporine modified...
...Neoral and Myfortic from Novartis; and Cellcept from Roche, as well as generics of Sandimmune, Neoral...
BioCentury | Jun 5, 2006
Product Development

Opportunity d’Lux

...explains their immunosuppressive activity. However, marketed calcineurin inhibitors are associated with nephrotoxicity and metabolic disturbances. Neoral...
BioCentury | Nov 21, 2005
Clinical News

Certican everolimus regulatory update

...azathioprine. However, the panel recommended additional clinical studies of the compound in combination with NVS's Neoral...
BioCentury | Nov 18, 2005
Company News

FDA panel votes for additional Certican data

...azathioprine. However, the panel recommended additional clinical studies of the compound in combination with NVS's Neoral...
BioCentury | Oct 10, 2005
Clinical News

Certican everolimus regulatory update

...asked for clinical studies on a dosing regimen for the compound in combination with NVS's Neoral...
BioCentury | Sep 6, 2004
Clinical News

Certican everolimus regulatory update

...asked for clinical studies on a dosing regimen for the compound in combination with NVS's Neoral...
BioCentury | Aug 30, 2004
Company News

NVS gets second Certican approvable letter

...asked for clinical studies on a dosing regimen for the compound in combination with NVS's Neoral...
BioCentury | Jan 26, 2004
Clinical News

Simulect basiliximab and Zenapax daclizumab regulatory update

...initial or maintenance immunosuppressive therapy, a doctors' choice between Prograf tacrolimus from Fujisawa and NVS's Neoral...
Items per page:
1 - 10 of 67